Hoth Therapeutics Stock (NASDAQ: HOTH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 133.00 / 3.65M |
Day Range | - - - |
52 Wk Range | 0.58 - 1.73 |
Market Cap | $6.31M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 3.2% |
Days to Cover | 1.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Hoth Therapeutics (NASDAQ:HOTH) through any online brokerage.
Other companies in Hoth Therapeutics’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
Hoth Therapeutics has a consensus price target of $7.08.
The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $0.9133 last updated September 24, 2024 at 4:57 AM EDT.
There are no upcoming dividends for Hoth Therapeutics.
Hoth Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Hoth Therapeutics.
Hoth Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.